Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2005 | 12-2004 | 09-2004 | 06-2004 | 03-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,270 | -13,040 | -10,040 | -8,680 | -4,020 |
| Depreciation Amortization | 100 | 470 | 360 | 240 | 110 |
| Other Working Capital | -1,800 | -1,140 | -1,880 | -160 | -1,430 |
| Operating Cash Flow | $-2,970 | $-13,710 | $-11,560 | $-8,600 | $-5,340 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -160 | -150 | -140 | -30 |
| Other Investing Activity | 0 | 0 | 10 | 0 | 0 |
| Investing Cash Flow | $0 | $-160 | $-140 | $-140 | $-30 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | 1 | -1 | 0 | 0 | 0 |
| Other Financing Activity | -191 | 3,301 | 3,240 | 720 | 160 |
| Financing Cash Flow | $-190 | $3,300 | $3,240 | $720 | $160 |
| Beginning Cash Position | 12,700 | 23,280 | 23,280 | 23,280 | 23,280 |
| End Cash Position | 9,540 | 12,700 | 14,820 | 15,260 | 18,060 |
| Net Cash Flow | $-3,160 | $-10,570 | $-8,460 | $-8,020 | $-5,220 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,970 | -13,710 | -11,560 | -8,600 | -5,340 |
| Free Cash Flow | -2,970 | -13,710 | -11,560 | -8,600 | -5,340 |